DIVIDEND ANNOUNCEMENT: iShares U.S. Pharmaceuticals ETF/iShares Trust (NYSE:IHE) on 03/22/2023 declared a dividend of $0.6720 per share

iShares U.S. Pharmaceuticals ETF/iShares Trust (NYSE:IHE) on 03/22/2023 declared a dividend of $ 0.6720 per share payable on March 29, 2023 to shareholders of record as of March 24, 2023. Dividend amount recorded is a decrease of $ 0.6651 from last dividend Paid.

iShares U.S. Pharmaceuticals ETF/iShares Trust (NYSE:IHE) has paid dividends since 2006, has a current dividend yield of 2.0703411102% and has increased its dividends for 2 successive years.

iShares U.S. Pharmaceuticals ETF/iShares Trust's market cap is $ 357,453,170 and has a PE ratio of 0.00. The stock price closed yesterday at $ 174.37 and has a 52 week low/high of $ 166.99 and $ 202.77.

iShares U.S. Pharmaceuticals is an open-end management investment company. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. As of Apr 30 2015, the Fund's total assets were $1,327,464,741 and the Fund's investment portfolio was valued at $1,323,343,176.

For more information on iShares U.S. Pharmaceuticals ETF/iShares Trust click here.